Medtronic (MDT) — insider trading
Health Care · NYSE
Medtronic (MDT) has 78 reported SEC Form 4 insider transactions in our data, including 4 open-market sales among the most recent 78 (latest 2026-09-16).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | KIIL HARRY SKIP | Officer (EVP & President Cardiovascular) | Open-market sale | 1,483 | $93.65 | $138.9K | Form 4 |
| 2026-09-15 | Blomquist Denise L. | Officer (Chief Accounting Officer) | Bona fide gift | 600 | — | $0 | Form 4 |
| 2026-08-20 | Marinaro Michael | Officer (EVP, Pres MedSurg and Americas) | Shares withheld for taxes / exercise cost | 1,084 | $92.30 | $100.1K | Form 4 |
| 2026-08-03 | Martha Geoffrey | Director, Officer (Chairman and CEO) | Grant / award / vesting (derivative) | 273,150 | — | $0 | Form 4 |
| 2026-08-03 | Martha Geoffrey | Director, Officer (Chairman and CEO) | Grant / award / vesting (derivative) | 295,002 | — | $0 | Form 4 |
| 2026-08-03 | Martha Geoffrey | Director, Officer (Chairman and CEO) | Grant / award / vesting (derivative) | 103,831 | — | $0 | Form 4 |
| 2026-08-03 | Martha Geoffrey | Director, Officer (Chairman and CEO) | Grant / award / vesting | 41,533 | — | $0 | Form 4 |
| 2026-08-03 | KIIL HARRY SKIP | Officer (EVP & President Cardiovascular) | Grant / award / vesting (derivative) | 65,556 | — | $0 | Form 4 |
| 2026-08-03 | KIIL HARRY SKIP | Officer (EVP & President Cardiovascular) | Grant / award / vesting (derivative) | 23,074 | — | $0 | Form 4 |
| 2026-08-03 | KIIL HARRY SKIP | Officer (EVP & President Cardiovascular) | Grant / award / vesting | 9,230 | — | $0 | Form 4 |
| 2026-08-03 | Marinaro Michael | Officer (EVP, Pres MedSurg and Americas) | Grant / award / vesting (derivative) | 77,848 | — | $0 | Form 4 |
| 2026-08-03 | Marinaro Michael | Officer (EVP, Pres MedSurg and Americas) | Grant / award / vesting (derivative) | 27,400 | — | $0 | Form 4 |
| 2026-08-03 | Marinaro Michael | Officer (EVP, Pres MedSurg and Americas) | Grant / award / vesting | 46,147 | — | $0 | Form 4 |
| 2026-08-03 | Marinaro Michael | Officer (EVP, Pres MedSurg and Americas) | Grant / award / vesting | 10,960 | — | $0 | Form 4 |
| 2026-08-03 | Pieton Thierry | Officer (EVP & Chief Financial Officer) | Grant / award / vesting (derivative) | 81,945 | — | $0 | Form 4 |
| 2026-08-03 | Pieton Thierry | Officer (EVP & Chief Financial Officer) | Grant / award / vesting (derivative) | 28,842 | — | $0 | Form 4 |
| 2026-08-03 | Pieton Thierry | Officer (EVP & Chief Financial Officer) | Grant / award / vesting | 11,537 | — | $0 | Form 4 |
| 2026-08-03 | Quinn Michelle | Officer (EVP, GC and Secretary) | Grant / award / vesting (derivative) | 45,070 | — | $0 | Form 4 |
| 2026-08-03 | Quinn Michelle | Officer (EVP, GC and Secretary) | Grant / award / vesting (derivative) | 15,863 | — | $0 | Form 4 |
| 2026-08-03 | Quinn Michelle | Officer (EVP, GC and Secretary) | Grant / award / vesting | 6,346 | — | $0 | Form 4 |
| 2026-08-03 | Thompson Kweli | Officer (EVP & President, Neuroscience) | Grant / award / vesting (derivative) | 49,167 | — | $0 | Form 4 |
| 2026-08-03 | Thompson Kweli | Officer (EVP & President, Neuroscience) | Grant / award / vesting (derivative) | 17,306 | — | $0 | Form 4 |
| 2026-08-03 | Thompson Kweli | Officer (EVP & President, Neuroscience) | Grant / award / vesting | 6,923 | — | $0 | Form 4 |
| 2026-08-03 | Walter Matthew R. | Officer (SVP, Chief HR Officer) | Grant / award / vesting (derivative) | 40,973 | — | $0 | Form 4 |
| 2026-08-03 | Walter Matthew R. | Officer (SVP, Chief HR Officer) | Grant / award / vesting (derivative) | 14,421 | — | $0 | Form 4 |
| 2026-08-03 | Walter Matthew R. | Officer (SVP, Chief HR Officer) | Grant / award / vesting | 5,769 | — | $0 | Form 4 |
| 2026-08-03 | Blomquist Denise L. | Officer (Chief Accounting Officer) | Grant / award / vesting (derivative) | 1,366 | — | $0 | Form 4 |
| 2026-08-03 | Blomquist Denise L. | Officer (Chief Accounting Officer) | Grant / award / vesting (derivative) | 2,337 | — | $0 | Form 4 |
| 2026-08-03 | Blomquist Denise L. | Officer (Chief Accounting Officer) | Grant / award / vesting | 2,337 | — | $0 | Form 4 |
| 2026-07-31 | Martha Geoffrey | Director, Officer (Chairman and CEO) | Shares withheld for taxes / exercise cost | 15,810 | $85.39 | $1.35M | Form 4 |
| 2026-07-31 | KIIL HARRY SKIP | Officer (EVP & President Cardiovascular) | Shares withheld for taxes / exercise cost | 3,074 | $85.39 | $262.5K | Form 4 |
| 2026-07-31 | Marinaro Michael | Officer (EVP, Pres MedSurg and Americas) | Shares withheld for taxes / exercise cost | 3,356 | $85.39 | $286.6K | Form 4 |
| 2026-07-31 | Thompson Kweli | Officer (EVP & President, Neuroscience) | Shares withheld for taxes / exercise cost | 1,739 | $85.39 | $148.5K | Form 4 |
| 2026-07-31 | Walter Matthew R. | Officer (SVP, Chief HR Officer) | Shares withheld for taxes / exercise cost | 1,675 | $85.39 | $143.0K | Form 4 |
| 2026-07-31 | Blomquist Denise L. | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 212 | $85.39 | $18.1K | Form 4 |
| 2026-07-28 | Quinn Michelle | Officer (EVP, GC and Secretary) | Shares withheld for taxes / exercise cost | 2,069 | $86.88 | $179.8K | Form 4 |
| 2026-07-08 | Walter Matthew R. | Officer (SVP, Chief HR Officer) | Open-market sale | 3,102 | $83.15 | $257.9K | Form 4 |
| 2026-06-08 | KIIL HARRY SKIP | Officer (EVP & President Cardiovascular) | Open-market sale | 228 | $80.45 | $18.3K | Form 4 |
| 2026-06-08 | KIIL HARRY SKIP | Officer (EVP & President Cardiovascular) | Open-market sale | 3,961 | $80.44 | $318.6K | Form 4 |
| 2026-06-05 | Blomquist Denise L. | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 237 | $83.32 | $19.7K | Form 4 |
| 2026-06-04 | Walter Matthew R. | Officer (SVP, Chief HR Officer) | Shares withheld for taxes / exercise cost | 2,840 | $83.32 | $236.6K | Form 4 |
| 2026-06-04 | Marinaro Michael | Officer (EVP, Pres MedSurg and Americas) | Shares withheld for taxes / exercise cost | 7,471 | $83.32 | $622.5K | Form 4 |
| 2026-06-04 | Martha Geoffrey | Director, Officer (Chairman and CEO) | Shares withheld for taxes / exercise cost | 41,936 | $83.32 | $3.49M | Form 4 |
| 2026-06-04 | KIIL HARRY SKIP | Officer (EVP & President Cardiovascular) | Shares withheld for taxes / exercise cost | 6,817 | $83.32 | $568.0K | Form 4 |
| 2026-05-26 | Blomquist Denise L. | Officer (Chief Accounting Officer) | Option exercise / conversion (derivative) | 1,621 | — | $0 | Form 4 |
| 2026-05-26 | Blomquist Denise L. | Officer (Chief Accounting Officer) | Option exercise / conversion | 1,712 | — | $0 | Form 4 |
| 2026-05-26 | KIIL HARRY SKIP | Officer (EVP & President Cardiovascular) | Option exercise / conversion (derivative) | 14,517 | — | $0 | Form 4 |
| 2026-05-26 | KIIL HARRY SKIP | Officer (EVP & President Cardiovascular) | Option exercise / conversion | 15,195 | — | $0 | Form 4 |
| 2026-05-26 | Marinaro Michael | Officer (EVP, Pres MedSurg and Americas) | Option exercise / conversion (derivative) | 17,093 | — | $0 | Form 4 |
| 2026-05-26 | Marinaro Michael | Officer (EVP, Pres MedSurg and Americas) | Option exercise / conversion | 18,994 | — | $0 | Form 4 |
| 2026-05-26 | Martha Geoffrey | Director, Officer (Chairman and CEO) | Option exercise / conversion (derivative) | 85,461 | — | $0 | Form 4 |
| 2026-05-26 | Martha Geoffrey | Director, Officer (Chairman and CEO) | Option exercise / conversion | 94,963 | — | $0 | Form 4 |
| 2026-05-26 | Wall Brett A. | Officer (EVP & Pres Neuroscience) | Option exercise / conversion (derivative) | 24,214 | — | $0 | Form 4 |
| 2026-05-26 | Wall Brett A. | Officer (EVP & Pres Neuroscience) | Option exercise / conversion | 26,907 | — | $0 | Form 4 |
| 2026-05-26 | Walter Matthew R. | Officer (SVP, Chief HR Officer) | Option exercise / conversion (derivative) | 8,449 | — | $0 | Form 4 |
| 2026-05-26 | Walter Matthew R. | Officer (SVP, Chief HR Officer) | Option exercise / conversion | 9,149 | — | $0 | Form 4 |
| 2026-05-01 | Walter Matthew R. | Officer (SVP, Chief HR Officer) | Shares withheld for taxes / exercise cost | 35 | $80.00 | $2.8K | Form 4 |
| 2026-04-28 | ARNOLD CRAIG | Director | Shares withheld for taxes / exercise cost | 207 | $81.90 | $17.0K | Form 4 |
| 2026-04-28 | DONNELLY SCOTT C | Director | Shares withheld for taxes / exercise cost | 207 | $81.90 | $17.0K | Form 4 |
| 2026-04-28 | Fonseca Lidia | Director | Shares withheld for taxes / exercise cost | 207 | $81.90 | $17.0K | Form 4 |
| 2026-04-28 | HOGAN RANDALL J | Director | Shares withheld for taxes / exercise cost | 207 | $81.90 | $17.0K | Form 4 |
| 2026-04-28 | Lewis Gregory P | Director | Shares withheld for taxes / exercise cost | 207 | $81.90 | $17.0K | Form 4 |
| 2026-04-28 | Lofton Kevin E | Director | Shares withheld for taxes / exercise cost | 207 | $81.90 | $17.0K | Form 4 |
| 2026-04-28 | NABEL ELIZABETH G | Director | Shares withheld for taxes / exercise cost | 207 | $81.90 | $17.0K | Form 4 |
| 2026-04-28 | Powell Kendall J | Director | Shares withheld for taxes / exercise cost | 207 | $81.90 | $17.0K | Form 4 |
| 2026-04-28 | Blomquist Denise L. | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 318 | $81.90 | $26.0K | Form 4 |
| 2026-04-27 | ARNOLD CRAIG | Director | Grant / award / vesting | 2,111 | — | $0 | Form 4 |
| 2026-04-27 | DONNELLY SCOTT C | Director | Grant / award / vesting | 2,111 | — | $0 | Form 4 |
| 2026-04-27 | Fonseca Lidia | Director | Grant / award / vesting | 2,111 | — | $0 | Form 4 |
| 2026-04-27 | Groetelaars John P | Director | Grant / award / vesting | 1,444 | — | $0 | Form 4 |
| 2026-04-27 | HOGAN RANDALL J | Director | Grant / award / vesting | 2,111 | — | $0 | Form 4 |
| 2026-04-27 | Jellison William R | Director | Grant / award / vesting | 1,444 | — | $0 | Form 4 |
| 2026-04-27 | Lee Joon Sup | Director | Grant / award / vesting | 1,803 | — | $0 | Form 4 |
| 2026-04-27 | Lewis Gregory P | Director | Grant / award / vesting | 2,111 | — | $0 | Form 4 |
| 2026-04-27 | Lofton Kevin E | Director | Grant / award / vesting | 2,111 | — | $0 | Form 4 |
| 2026-04-27 | NABEL ELIZABETH G | Director | Grant / award / vesting | 2,111 | — | $0 | Form 4 |
| 2026-04-27 | Powell Kendall J | Director | Grant / award / vesting | 2,111 | — | $0 | Form 4 |
| 2026-04-27 | Blomquist Denise L. | Officer (Chief Accounting Officer) | Grant / award / vesting | 1,508 | — | $0 | Form 4 |
Ask the chat about MDT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Medtronic (MDT).
Last updated 2026-09-16 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.